Related references
Note: Only part of the references are listed.Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Chromatin marks identify critical cell types for fine mapping complex trait variants
Gosia Trynka et al.
NATURE GENETICS (2013)
Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
Mia Kero et al.
NEUROBIOLOGY OF AGING (2013)
Human Genetics in Rheumatoid Arthritis Guides a High-Throughput Drug Screen of the CD40 Signaling Pathway
Gang Li et al.
PLOS GENETICS (2013)
Five Years of GWAS Discovery
Peter M. Visscher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Low-Density Lipoprotein Receptor Gene Familial Hypercholesterolemia Variant Database: Update and Pathological Assessment
Ebele Usifo et al.
ANNALS OF HUMAN GENETICS (2012)
Therapeutic targeting of the complement system in age-related macular degeneration: a review
Robyn Troutbeck et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
Kenneth J. Katschke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Will Cholesteryl Ester Transfer Protein Inhibition Succeed Primarily by Lowering Low-Density Lipoprotein Cholesterol?
Sekar Kathiresan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Evan A. Stein et al.
LANCET (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Use of genome-wide association studies for drug repositioning
Philippe Sanseau et al.
NATURE BIOTECHNOLOGY (2012)
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
Steve Eyre et al.
NATURE GENETICS (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada et al.
NATURE GENETICS (2012)
Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles
Benjamin P. Fairfax et al.
NATURE GENETICS (2012)
Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis
Eli A. Stahl et al.
NATURE GENETICS (2012)
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Lam C. Tsoi et al.
NATURE GENETICS (2012)
Cholesterol-lowering blockbuster candidates speed into Phase III trials
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Evan A. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes
Daniel G. MacArthur et al.
SCIENCE (2012)
Lighting the fires within: the cell biology of autoinflammatory diseases
Heiyoung Park et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets
Xinli Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Riluzole pharmacokinetics in young patients with spinal muscular atrophy
Chadi Abbara et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
What makes a good drug target?
Isabella Gashaw et al.
DRUG DISCOVERY TODAY (2011)
Progress and Promise of Genome-Wide Association Studies for Human Complex Trait Genetics
Barbara E. Stranger et al.
GENETICS (2011)
An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea
Donatello Salvatore et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
Soumya Raychaudhuri et al.
NATURE GENETICS (2011)
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease
Manuel A. Rivas et al.
NATURE GENETICS (2011)
Competitiveness in follow-on drug R&D: a race or imitation?
Joseph A. DiMasi et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Phase II failures: 2008-2010
John Arrowsmith
NATURE REVIEWS DRUG DISCOVERY (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now?
Philip Barter et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology
Elizabeth J. Rossin et al.
PLOS GENETICS (2011)
Spinal muscular atrophy: mechanisms and therapeutic strategies
Christian L. Lorson et al.
HUMAN MOLECULAR GENETICS (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Uncovering the roles of rare variants in common disease through whole-genome sequencing
Elizabeth T. Cirulli et al.
NATURE REVIEWS GENETICS (2010)
New Therapeutic Approaches to Mendelian Disorders
Harry C. Dietz
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS
Dan L. Nicolae et al.
PLOS GENETICS (2010)
Laminopathies and the long strange trip from basic cell biology to therapy
Howard J. Worman et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Common variants at 30 loci contribute to polygenic dyslipidemia
Sekar Kathiresan et al.
NATURE GENETICS (2009)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
OPINION A network view of disease and compound screening
Eric E. Schadt et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
OPINION Assessing the translatability of drug projects: what needs to be scored to predict success?
Martin Wehling
NATURE REVIEWS DRUG DISCOVERY (2009)
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
Lucia A. Hindorff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes
Sergey Nejentsev et al.
SCIENCE (2009)
Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions
Soumya Raychaudhuri et al.
PLOS GENETICS (2009)
Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13
Ralph Burkhardt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders
M. Estacion et al.
JOURNAL OF NEUROSCIENCE (2008)
ProTx-II, a Selective Inhibitor of Nav1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors
William A. Schmalhofer et al.
MOLECULAR PHARMACOLOGY (2008)
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
Soumya Raychaudhuri et al.
NATURE GENETICS (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
Mark I. McCarthy et al.
NATURE REVIEWS GENETICS (2008)
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome
Benjamin S. Brooke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic Mapping in Human Disease
David Altshuler et al.
SCIENCE (2008)
Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?
Shah Ebrahim et al.
HUMAN GENETICS (2008)
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
Joost P. H. Drenth et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
Variation in complement factor 3 is associated with risk of age-related macular degeneration
Julian B. Maller et al.
NATURE GENETICS (2007)
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Michiel L. Bots et al.
LANCET (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
SCN9A mutations in paroxysmal extreme pain disorder:: Allelic variants underlie distinct channel defects and phenotypes
Caroline R. Fertleman et al.
NEURON (2006)
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration
Julian Maller et al.
NATURE GENETICS (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A spectrum of PCSK9 Alleles contributes to plasma levels of low-density lipoprotein cholesterol
IK Kotowski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden:: Association of susceptibility with PTPN22, CTLA4, and PADI4
RM Plenge et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
A haplotype map of the human genome
D Altshuler et al.
NATURE (2005)
Chemical genetics and orphan genetic diseases
MR Lunn et al.
CHEMISTRY & BIOLOGY (2005)
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels
JPH Drenth et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Complement factor H polymorphism in age-related macular degeneration
RJ Klein et al.
SCIENCE (2005)
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
C Jonathan et al.
NATURE GENETICS (2005)
Genome-wide association studies for common diseases and complex traits
JN Hirschhorn et al.
NATURE REVIEWS GENETICS (2005)
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia
Y Yang et al.
JOURNAL OF MEDICAL GENETICS (2004)
Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
P Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver
SW Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
KN Maxwell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Lamin A truncation in Hutchinson-Gilford progeria
A De Sandre-Giovannoli et al.
SCIENCE (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
A phase 1 trial of Riluzole in spinal muscular atrophy
BS Russman et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
